Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07391956 · ClinicalTrials.gov registry record · NA
Tier Palliative Care For Patients With Advanced Heart Failure or Cancer
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Not yet
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT07391956 is a NA study that has not yet begun recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 400 participants.
The verdict
NCT07391956, a NA study, has not yet begun recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
TIER-PC is an adaptive model of delivering palliative care that provides the right level of care to the right patients at the right time. It represents an adaption of the Mount Sinai PALLIATIVE CARE AT HOME (PC@H) program, which delivers home-based palliative care. TIER-PC increases the number and intensity of disciplines added to the patient's care team as their symptoms worsen and function declines. In Tier 1, patients who are able to care for themselves and no/mild symptoms receive a community health worker (CHW) trained to elicit illness understanding in a culturally competent way. In Tier 2, for patients with poorer function and mild symptoms, a social worker (SW), trained in serious illness communication, joins the CHW to further elicit patients' goals and prognostic understanding while communicating symptom needs to their primary clinician. In Tier 3, as function decreases and symptoms increase, an advance practice nurse (APN) joins the CHW and SW to manage complex symptoms. Finally, in Tier 4, for those older adults with the poorest function and most complex symptoms, a physician joins the team to ensure that the most complex needs (e.g., end-of-life treatment preferences and multifaceted symptom control) are met. The CHW follows patients longitudinally across all tiers and re-allocates them to the appropriate tier based on their evolving needs.
Interventions
- BEHAVIORAL Community Health Worker
- BEHAVIORAL Tier-Palliative Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2032-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07391956
The ClinicalTrials.gov registry entry for NCT07391956 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Community Health Worker is the first listed.
NCT07391956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07391956 about?
NCT07391956 is a clinical study titled "Tier Palliative Care For Patients With Advanced Heart Failure or Cancer". TIER-PC is an adaptive model of delivering palliative care that provides the right level of care to the right patients at the right time. It represents an adaption of the Mount Sinai PALLIATIVE CARE AT HOME (PC@H) program, which delivers home-based palliative care. TIER-PC increases the number and i...
What is the current status of trial NCT07391956?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2026-05-01. Estimated completion is 2032-01-31.
What interventions are being tested in trial NCT07391956?
The interventions under investigation include: Community Health Worker (BEHAVIORAL), Tier-Palliative Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT07391956?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.